Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arvind Ravi

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Genes & Development|May 1, 2013
Let-7 represses Nr6a1 and a mid-gestation developmental program in adult fibroblastsAllan M Gurtan, Arvind Ravi, Peter B Rahl, et al.
The Oncologist|March 16, 2022
Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial CarcinomaPraful Ravi, Arvind Ravi, Irbaz B Riaz, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Single Cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathwayIvan Juric, Emily E Fink, Hong Qiu, et al.
NPJ Precision Oncology|September 27, 2025
Single-cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathwayIvan Juric, Emily E Fink, Hong Qiu, et al.
JAMIA Open|May 8, 2026
Design and implementation of an end-to-end AI-driven colonoscopy recall workflow at scaleAman Mohapatra, Rachel Porth, Si Wong, et al.
Clinical Genitourinary Cancer|April 9, 2026
Radiation and Avelumab in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder CancerKent W Mouw, Kee-Young Shin, James Parisi, et al.
Journal for Immunotherapy of Cancer|June 1, 2022
Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancerMiguel Lopez de Rodas, Venkata Nagineni, Arvind Ravi, et al.
Journal for Immunotherapy of Cancer|February 3, 2024
Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancerPraful Ravi, Dory Freeman, Jonathan Thomas, et al.
Cell Reports|February 23, 2023
TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent stateSatoru Matsuda, Ajinkya Revandkar, Taronish D Dubash, et al.
The Journal of Experimental Medicine|November 25, 2024
Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancerCamila Robles-Oteíza, Katherine Hastings, Jungmin Choi, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Genes & Development|May 1, 2013
Let-7 represses Nr6a1 and a mid-gestation developmental program in adult fibroblastsAllan M Gurtan, Arvind Ravi, Peter B Rahl, et al.
The Oncologist|March 16, 2022
Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial CarcinomaPraful Ravi, Arvind Ravi, Irbaz B Riaz, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Single Cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathwayIvan Juric, Emily E Fink, Hong Qiu, et al.
NPJ Precision Oncology|September 27, 2025
Single-cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathwayIvan Juric, Emily E Fink, Hong Qiu, et al.
JAMIA Open|May 8, 2026
Design and implementation of an end-to-end AI-driven colonoscopy recall workflow at scaleAman Mohapatra, Rachel Porth, Si Wong, et al.
Clinical Genitourinary Cancer|April 9, 2026
Radiation and Avelumab in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder CancerKent W Mouw, Kee-Young Shin, James Parisi, et al.
Journal for Immunotherapy of Cancer|June 1, 2022
Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancerMiguel Lopez de Rodas, Venkata Nagineni, Arvind Ravi, et al.
Journal for Immunotherapy of Cancer|February 3, 2024
Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancerPraful Ravi, Dory Freeman, Jonathan Thomas, et al.
Cell Reports|February 23, 2023
TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent stateSatoru Matsuda, Ajinkya Revandkar, Taronish D Dubash, et al.
The Journal of Experimental Medicine|November 25, 2024
Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancerCamila Robles-Oteíza, Katherine Hastings, Jungmin Choi, et al.
Pageof 3